New Haldol Warning Label

By Christina Bruni, Health Guide Thursday, September 20, 2007

- A
- A
- A

The U.S. Food and Drug Administration now requires new labeling on Johnson & Johnson's Haldol (generic: Haloperidol) noting QT prolongation and Torsades de Pointes as serious side effects. A number of case reports indicated sudden death, most where patients took the drug at higher doses than ...

Read the rest of this post >>

Recovery: Defining It and Living It

Hide Comments | Add comment

Don Fraser

9/20/07 11:43pm

You raise an interesting philosophical point. If a person is at risk for taking a certain drug, is the risk worth the chance if the drug is effective in controlling symptoms. Cancer patients who undergo chemotherapy experience tremendous discomfort, yet they choose to have the treatment . In other words , if something works for schizophrenia if the odds are in your favor (that is,you do not have a conflicting medical condition) the tendency would be to go with it .

Janet

9/21/07 6:28pm

I agree with both you and Don concerning Haldol. while the drug did not work for me I realize it has helped many patients. I would be curious to see if there were other factors that could have caused the death or deaths of the various patients. With all drugs a person with their doctor must decide whether or not a drug's benefits out weighs its side effects.

New Haldol Warning Label

Ask a Question